Telesis Bio, Inc. - Common Stock (TBIO)
Competitors to Telesis Bio, Inc. - Common Stock (TBIO)
Ginkgo Bioworks Holdings, Inc. DNA -2.28%
Ginkgo Bioworks is focused on building custom microbes for customers in various industries, utilizing advanced robotics and automation in its biomanufacturing processes. While Telesis Bio provides critical tools for DNA synthesis, Ginkgo emphasizes its ability to design and scale biology for commercial applications. Ginkgo's strong backing in synthetic biology, along with significant partnerships and investments, gives it a competitive advantage in large-scale, application-driven initiatives. Nonetheless, Telesis Bio focuses on providing foundational technologies that support custom and research-driven genetic constructions, which positions it uniquely within niche markets.
Illumina, Inc. ILMN -3.02%
Illumina is a leader in sequencing and array-based technologies, providing high-throughput sequencing solutions that encompass a wide range of genomic applications. Telesis Bio, which specializes in DNA synthesis and amplification technologies, competes by focusing on providing higher precision and custom solutions that cater to specialized research needs. While Illumina leads with its extensive market presence and established technology, Telesis Bio differentiates itself through innovation in its product offerings, specifically in the synthesis and assembly of long and complex DNA molecules.
Thermo Fisher Scientific Inc. TMO -6.83%
Thermo Fisher Scientific offers a broad portfolio of instruments and reagents for genetic analysis and molecular biology, which includes DNA synthesis and manipulation tools. Telesis Bio competes by emphasizing its proprietary platforms for more efficient and scalable DNA synthesis. Although Thermo Fisher has a significant market share and comprehensive service offerings that provide a competitive edge through established customer relationships and a broad product range, Telesis Bio aims to carve out its niche by focusing on rapid DNA synthesis and the speed of delivery for custom applications.
Twist Bioscience Corporation TWST -3.64%
Twist Bioscience focuses on high-throughput DNA synthesis and has gained attention with its silicon-based DNA synthesis technology that offers precision and cost-effectiveness. Telesis Bio competes by promoting its own unique synthesis methods that cater to specific research applications and length complexities of DNA. While Twist has a strong reputation for economies of scale and rapid production, Telesis Bio aims to differentiate itself with high-quality custom solutions tailored for advanced research and development projects. This highlights a more specialized approach versus the more general focus of Twist.